Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 12 Breast Neoplasms 11 Prostatic Neoplasms 5 Lung Neoplasms 5 Colorectal Neoplasms 5 Uterine Cervical Neoplasms 4 Thyroid Neoplasms 2 Smoking Cessation 2 Motor Activity 2 Lymphoma 2 Hematologic Neoplasms 2 Communication 2 Uveal Melanoma 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Tobacco Use Cessation 1 Thyroid Diseases 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Sexual Dysfunction, Physiological 1 Sedentary Behavior 1 Rectal Neoplasms 1 Patient Preference 1 Patient Acceptance of Health Care 1 Papillomavirus Infections 1 Papillary Thyroid Microcarcinoma 1 Neoplasms, Plasma Cell 1 Multiple Myeloma 1 Melanoma 1

Interventions

Temozolomide 264 Radiotherapy 119 Bevacizumab 105 Magnetic Resonance Spectroscopy 59 Radiation 47 pembrolizumab 30 Irinotecan 28 Surgical Procedures, Operative 23 Lomustine 21 Specimen Handling 19 Nivolumab 19 Radiosurgery 18 Carmustine 18 Aminolevulinic Acid 16 Erlotinib Hydrochloride 15 Drug Therapy 15 Blood Specimen Collection 14 Radiotherapy, Intensity-Modulated 13 O(6)-benzylguanine 13 Chemotherapy, Adjuvant 13 Carboplatin 13 Filgrastim 11 Cyclophosphamide 11 sargramostim 10 poly ICLC 10 atezolizumab 10 Thalidomide 10 Etoposide 10 Ipilimumab 9 Everolimus 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Glioblastoma × Focus Groups × Clear all

NCT03454295 2024-04-01

Easing Psychosocial Burden for Informal Caregivers

Memorial Sloan Kettering Cancer Center

Phase EARLY_PHASE1 Completed

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡